BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8562839)

  • 1. Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparin.
    Macklon NS; Greer IA; Reid AW; Walker ID
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):672-5. PubMed ID: 8562839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annotation. Thromboembolism in pregnancy and its management.
    Letsky E; de Swiet M
    Br J Haematol; 1984 Aug; 57(4):543-52. PubMed ID: 6430334
    [No Abstract]   [Full Text] [Related]  

  • 3. How I treat heterozygous hereditary antithrombin deficiency in pregnancy.
    Bramham K; Retter A; Robinson SE; Mitchell M; Moore GW; Hunt BJ
    Thromb Haemost; 2013 Sep; 110(3):550-9. PubMed ID: 23903049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hereditary antithrombin deficiency and pregnancy. Pregnancy course in six women with known hereditary antithrombin deficiency].
    Mohapeloa HL; Wellnitz H; Laursen B
    Ugeskr Laeger; 1998 Nov; 160(49):7130-4. PubMed ID: 9850619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series.
    Rodie VA; Thomson AJ; Stewart FM; Quinn AJ; Walker ID; Greer IA
    BJOG; 2002 Sep; 109(9):1020-4. PubMed ID: 12269676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency.
    Rogenhofer N; Bohlmann MK; Beuter-Winkler P; Würfel W; Rank A; Thaler CJ; Toth B
    Ann Hematol; 2014 Mar; 93(3):385-92. PubMed ID: 23999648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin therapy for congenital antithrombin III deficiency in pregnancy.
    Neerhof MG; Krewson DP; Haut M; Librizzi RJ
    Am J Perinatol; 1993 Jul; 10(4):311-2. PubMed ID: 8397570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of fraxiparin for the prevention and treatment of thromboembolism in patients with heparin-induced thrombocytopenia].
    Barkagan ZS
    Ter Arkh; 1993; 65(10):77-82. PubMed ID: 8296242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization.
    Kligman I; Noyes N; Benadiva CA; Rosenwaks Z
    Fertil Steril; 1995 Mar; 63(3):673-6. PubMed ID: 7851607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin, a low-molecular-weight heparin suppresses prothrombin activation more effectively than unfractionated heparin in patients treated for venous thromboembolism.
    Grosset AB; Spiro TE; Beynon J; Rodgers GM
    Thromb Res; 1997 Jun; 86(5):349-54. PubMed ID: 9211625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism.
    de Swiet M
    Clin Haematol; 1985 Oct; 14(3):643-60. PubMed ID: 3907913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital antithrombin III deficient neonate treated with antithrombin III concentrates.
    Shiozaki A; Arai T; Izumi R; Niiya K; Sakuragawa N
    Thromb Res; 1993 May; 70(3):211-6. PubMed ID: 8327986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies.
    Dulitzki M; Pauzner R; Langevitz P; Pras M; Many A; Schiff E
    Obstet Gynecol; 1996 Mar; 87(3):380-3. PubMed ID: 8598959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombosis, low-molecular-weight heparin-induced thrombocytopenia and labor].
    Lemesle FG; Mebroukine L; Ermacora P; Lhuillier P; Marfaing A; Wolf M
    Presse Med; 1998 Jan; 27(1):19. PubMed ID: 9767759
    [No Abstract]   [Full Text] [Related]  

  • 17. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is venous thrombembolism during pregnancy an indication for routine assay of antithrombin activity and antithrombin supplementation?].
    Barlik M; Seremak-Mrozikiewicz A; Drews K; Sobieszczyk S
    Ginekol Pol; 2010 Jan; 81(1):61-4. PubMed ID: 20232702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful administration of recombinant human antithrombin in a pregnant Japanese woman with hereditary antithrombin deficiency.
    Fujibe Y; Mariya T; Mizuuchi M; Ishioka S; Yoshida M; Saito T
    Taiwan J Obstet Gynecol; 2019 Nov; 58(6):849-851. PubMed ID: 31759540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
    Brandt P
    Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.